# Precirix: Research, Jette, Belgium

> Precirix: Precirix is a clinical-stage biotechnology company based in Brussels, Belgium, founded in 2014. Based in Jette, Belgium. Founded 2014.

Source: https://millionrounds.com/startup/precirix (Millionrounds; every figure on the page links to its filing or article)

Belgium · [Research startup](https://millionrounds.com/companies)

# Precirix

Precirix is a clinical-stage biotechnology company based in Brussels, Belgium, founded in 2014.

Funding reported Last round: Series B

Research Jette, Belgium

Company summary

- **Founded:** 2014 12 years old
- **Team:** 9 1 to 10 people
- **Funding reported:** 117M as listed, currency not stated
- **Last round:** Series B Mar 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Precirix has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Precirix

Precirix is a clinical-stage biotechnology company based in Brussels, Belgium, founded in 2014.

The company specializes in developing precision radiopharmaceuticals for cancer treatment, utilizing camelid single-domain antibodies (sdAbs) labeled with radioisotopes. Precirix focuses on oncology and targeted radionuclide therapy, aiming to provide personalized treatment options for cancer patients. The company has a diverse pipeline, including its lead product, CAM-H2, which is currently in a Phase I/II clinical trial targeting HER2-positive metastatic cancer. Precirix is also advancing programs targeting Fibroblast Activation Protein (FAP), which has the potential to be a first-in-class alpha-emitting therapy. Their theranostic approach combines imaging for patient selection with targeted alpha-emitting radiation, enhancing treatment precision and efficacy. With a dedicated team of approximately 22–35 employees, Precirix has successfully raised over $129 million in funding from various investors, positioning itself as a key player in the biotechnology industry focused on innovative cancer therapies.

## What company datasets say Precirix raised

Funding, as reported

Reported in all **117M** in the source's currency

Rounds **2**

Last round **Series B**

Last round size **88M**

Last round date **Mar 2022**

Investors listed **9**

## The company, in detail

What they build

Known for

biotechnologies biotechnology research targeted radionuclide therapy actinium225 hospital & health care camel derived antibodies oncology radiopharmaceuticals b2b single domain antibodies

Built with from their website

Microsoft Exchange Microsoft 365 Apps & Services Microsoft Exchange Online Microsoft 365 Outlook Microsoft Email Providers Mailgun HPLC

- **Sector:** Research
- **Industry code:** NAICS 541714, 325414
- **Region:** Brussels
- **Revenue:** 1.5M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/precirix)

## Research in Belgium

Startups like it

- [**Fyteko** Anderlecht · founded 2014 *Raised*](https://millionrounds.com/company/fyteko)
- [**Cellaïon** Mont-Saint-Guibert · founded 2021](https://millionrounds.com/startup/cella-on)
- [**Full-Life Technologies** Gembloux · founded 2021](https://millionrounds.com/startup/full-life-technologies)
- [**Augustine Therapeutics** Leuven · founded 2019](https://millionrounds.com/startup/augustine-therapeutics)
- [**NOVADIP Biosciences S.A.** Mont-Saint-Guibert · founded 2013](https://millionrounds.com/startup/novadip-biosciences-s-a)
- [**EyeD Pharma** Seraing · founded 2012](https://millionrounds.com/startup/eyed-pharma)
- [**atbtherapeutics** Marche-en-Famenne · founded 2018](https://millionrounds.com/startup/atbtherapeutics)
- [**Imcyse SA** Liege · founded 2011](https://millionrounds.com/startup/imcyse-sa)

## Is this your company?

Add your raise, your deck and your story, and put Precirix in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)